Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Francois Vergez"'
Autor:
Charles Dussiau, Thibault Comont, Camille Knosp, Ines Vergnolle, Clotilde Bravetti, Alban Canali, Amandine Houvert, Laetitia Largeaud, Christian Daveaux, Laila Zaroili, Chloe Friedrich, Ismael Boussaid, Loria Zalmai, Carole Almire, Odile Beyne-Rauzy, Lise Willems, Didier Bouscary, Olivier Gandrillon, Michaela Fontenay, Oliver Kosmider, Francois Vergez, Nicolas Chapuis
Publikováno v:
HemaSphere, Vol 7, p e87989c2 (2023)
Externí odkaz:
https://doaj.org/article/2a831e7f23544a9fac1e1b8a96ad5747
Autor:
Laetitia Largeaud, Matthew Collin, Nils Monselet, Francois Vergez, Vincent Fregona, Lise Larcher, Pierre Hirsch, Nicolas Duployez, Audrey Bidet, Isabelle Luquet, Jacinta Bustamante, Stephanie Dufrechou, Nais Prade, Marie Nolla, Camille Hamelle, Suzanne Tavitian, Christophe Habib, Mateo Meynier, Christine Bellanne-Chantelot, Jean Donadieu, Flore Sicre de Fontbrune, Claire Fieschi, Alina Ferster, Francois Delhommeau, Eric Delabesse, Marlene Pasquet
Publikováno v:
Haematologica, Vol 108, Iss 6 (2023)
Germline GATA2 mutations predispose to myeloid malignancies resulting from the progressive acquisition of additional somatic mutations. Here we describe clinical and biological features of 78 GATA2-deficient patients. Hematopoietic stem and progenito
Externí odkaz:
https://doaj.org/article/66d570b4c75a4f039dacadeac2564635
Autor:
Jean‐Baptiste Rieu, Lucie Coster, Jill Corre, Suzanne Tavitian, Christian Recher, Anne Huynh, Muriel Picard, Celine Derreumaux, Sarah Bertoli, Francois Vergez, Laetitia Largeaud
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 589-592 (2020)
Externí odkaz:
https://doaj.org/article/b25bc659a65741a8a222ad982e6e9124
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 408-408 (2020)
Externí odkaz:
https://doaj.org/article/7a22bfccf3e442e4a533d7323591381f
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 861-862 (2023)
Externí odkaz:
https://doaj.org/article/dc830c61061d4ab48a8205e53b23cf01
Autor:
Alexej Knaus, François Vergez, Cédric Garcia, Hartmut Engels, Hela Hundertmark, David Ribes, Laetitia Largeaud, Suzanne Tavitian, Bernard Payrastre, Peter Krawitz, Stanislas Faguer, Agnes Ribes
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/50324bb3ed984f5ca9c44b6435f727aa
Autor:
Sarah Bertoli, Muriel Picard, Emilie Bérard, Emmanuel Griessinger, Clément Larrue, Pierre Luc Mouchel, François Vergez, Suzanne Tavitian, Edwige Yon, Jean Ruiz, Eric Delabesse, Isabelle Luquet, Laetitia Karine Linares, Estelle Saland, Martin Carroll, Gwenn Danet-Desnoyers, Audrey Sarry, Françoise Huguet, Jean Emmanuel Sarry, Christian Récher
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation contribute to leukostasis and chemoresistance, dexamethasone added to chemotherapy could improv
Externí odkaz:
https://doaj.org/article/86476d42418e473e95c71aa081697f7f
Autor:
Etienne De Clara, Morgane Gourvest, Hanjing Ma, François Vergez, Marie Tosolini, Sébastien Dejean, Cécile Demur, Eric Delabesse, Christian Recher, Christian Touriol, Maria Paola Martelli, Brunangelo Falini, Pierre Brousset, Marina Bousquet
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
Long non-coding RNAs are defined as transcripts larger than 200 nucleotides but without protein-coding potential. There is growing evidence of the important role of long non-coding RNAs in cancer initiation, development and progression. In this study
Externí odkaz:
https://doaj.org/article/c990b321c1104d49a724b0cf5baef9b6
Autor:
François Vergez, Alexa S. Green, Jerome Tamburini, Jean-Emmanuel Sarry, Baptiste Gaillard, Pascale Cornillet-Lefebvre, Melanie Pannetier, Aymeric Neyret, Nicolas Chapuis, Norbert Ifrah, François Dreyfus, Stéphane Manenti, Cecile Demur, Eric Delabesse, Catherine Lacombe, Patrick Mayeux, Didier Bouscary, Christian Recher, Valerie Bardet
Publikováno v:
Haematologica, Vol 96, Iss 12 (2011)
Background Acute myeloid leukemias arise from a rare population of leukemic cells, known as leukemic stem cells, which initiate the disease and contribute to frequent relapses. Although the phenotype of these cells remains unclear in most patients, t
Externí odkaz:
https://doaj.org/article/4cd593019b8b441587d7e540492219c7